News

Media contact:
Molly Bowen  

CROI 2017 Highlighted ACTG Network Presentations

Post Date: 
2017-02-28
Source: 
ACTG Newsletter
A5274: Impact of INH adherence on TB incidence and mortality by week 96 in REMEMBER Trial Amita Gupta, MD, MHS, Baltimore-Washington-India Clinical Trials Unit, co-PI and Investigator, Johns Hopkins University Clinical Research Site The A5274/REMEMBER trial team previously reported that among those...

An undercurrent of fear in Baltimore's immigrant communities

Post Date: 
2017-02-23
Source: 
The Baltimore Sun
On Sunday Feb. 12, hundreds of Latino, African-American, white and Asian neighbors marched in Highlandtown to Patterson Park chanting "No hate, no fear, immigrants are welcome here!" Despite this moment of great solidarity, there was an undercurrent of fear among the undocumented immigrant...

emocha and miDiagnostics collaborate to achieve more comprehensive mobile testing

Post Date: 
2016-12-12
Source: 
iMedicalApps
Baltimore-based tech startup emocha is collaborating with miDIAGNOSTICS in order to combine hardware and software to augment current medical tests for patients and health care providers. Emocha is a Johns Hopkins startup spinout and the end goal is to utilize each company’s strengths to bring test...

In Bolivia, health workers use cell phones to eradicate Chagas disease

Post Date: 
2016-11-29
Source: 
Humanosphere
With real-time information, a better map emerges telling health officials where people might need treatment, and allows someone to schedule fumigation. Beyond that, eMOCHA allows health workers to log additional data, such as the number of family members in a home or the number of times it...

Bolivia: MSF develops an information system for exterminating the bugs that transmit Chagas

Post Date: 
2016-11-04
Source: 
Medecins Sans Frontieres
From this year, MSF is launching the central information system called eMOCHA in three municipalities within Narciso Campero Province in Bolivia. This system is a technological breakthrough that enables people to report the location of triatomine bugs or 'kissing bugs', the vector insects for...

Eight finalists announced for Beta City pitch competition

Post Date: 
2016-09-22
Source: 
Baltimore Business Journal
Eight early-stage companies — from app developers to an online consignment shop — will vie for $75,000 in prizes at Beta City’s Venture Capital Pitch Day competition on Sep. 29 at City Garage.

Emocha Mobile Health lands new contracts for its medication monitoring app

Post Date: 
2016-08-30
Source: 
The Baltimore Sun
A Baltimore startup with a mobile application to keep tuberculosis patients on track with their medication regimen is expanding with new contracts in California and big ideas for how the technology can improve oversight of medications for other illnesses. Emocha Mobile...

Digital health tools target medication adherence, population health

Post Date: 
2016-08-30
Source: 
mHealth Intelligence
Public health officials in three central California counties will be using a medication management app to help tuberculosis patients stick to their schedules. Officials in Contra Costa, Fresno and Merced counties are contracting with Emocha Mobile Health in a bid to curb the region’s high rate of...

Public-private partnerships critical in fight against infectious diseases

Post Date: 
2016-08-17
Source: 
Infectious Disease News (via Healio)
The threat of infectious diseases continues to drive innovation in the free market, resulting in improved or novel therapies and diagnostics. Among its benefits, the free market is a place where readily available resources can be used to tackle emerging threats. One example is the number of...

Imec’s miDiagnostics joint venture does blood tests from blood-drop

Post Date: 
2016-08-09
Source: 
Electronics Weekly
miDiagnostics, the joint venture between Imec and Johns Hopkins University, aims to develop IC-based diagnostic tests which use drops of blood to detect cells, proteins, nucleic acids, and/or small molecules.

Emocha brings TB adherence tech to California as part of national expansion

Post Date: 
2016-08-02
Source: 
MedCity News
Emocha, a digital health startup seeking to create more flexibility for tuberculosis patients to meet the requirements for Directly Observed Therapy, or DOT, has added a new set of customers in California as part of a national expansion.

emocha’s public health apps are heading to California

Post Date: 
2016-08-02
Source: 
Technical.ly Baltimore
Three counties in California signed on to use emocha’s apps for managing tuberculosis. The Johns Hopkins spinout is implementing miDOT in Fresno, Merced and Contra Costa counties.

Help on wheels to screen TB in rural areas

Post Date: 
2016-07-26
Source: 
The Times of India
A state-of the art health services bus would provide medical care to rural populace at their doorsteps. Designed through a donation of US$100,000 from philanthropists Raj and Bharati Shah of the US-based Capital Technology Information Services (CTIS), the mobile health and wellness clinic launched...

Health treatment isn’t affordable for middle income families

Post Date: 
2016-07-26
Source: 
Lokmat
Pune, India, local coverage of the Mobile Health and Wellness Clinic No link available

Medical treatment available at your doorstep

Post Date: 
2016-07-26
Source: 
Sakal Newspaper
Pune, India, local coverage of the Mobile Health and Wellness Clinic No link available

CTIS, BJMC with JHCCGHE launch mobile healthcare van in Pune

Post Date: 
2016-07-25
Source: 
Express Healthcare, The Indian Express
Maryland-based healthcare informatics company, CTIS, has collaborated with Johns Hopkins Center for Clinical Global Health Education (JHCCGHE) and Byramjee Jeejeebhoy Government Medical College (BJMC), to dispatch a custom-made mobile healthcare van in Pune, Maharashtra.

Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults

Post Date: 
2016-05-11
Source: 
Science Daily
An international review team has prepared a systematic review to assess the accuracy of a point-of-care urine test for diagnosing and screening tuberculosis (TB) in people living with human immunodeficiency virus (HIV).

Study evaluates four-drug TB treatment for HIV/AIDS patients

Post Date: 
2016-04-04
Source: 
Vaccine News Daily
"Our results even suggest the four-drug strategy is actually doing more harm than isoniazid-alone therapy because study participants found it less tolerable and stopped using it," Dr. Amita Gupta, senior study author and associate professor of medicine and deputy director of the Johns Hopkins...

Proactively treating HIV patients at risk for tuberculosis with multi-drug TB regimens doesn't save more lives

Post Date: 
2016-03-20
Source: 
Health Canal
The number one killer of HIV patients in resource-limited areas, including parts of Africa and India, is tuberculosis (TB), underscoring the need for optimal treatments and effective strategies to address this deadly co-infection. But TB is harder to detect in HIV-infected patients and diagnostic...

Proactively treating HIV patients at risk for tuberculosis with multi-drug TB regimens doesn't save more lives

Post Date: 
2016-03-18
Source: 
Infection Control Today
In what investigators say is a surprise finding, results of a new study appear to strongly affirm the effectiveness of prescribing the anti-tuberculosis drug isoniazid alone — in place of the standard four-drug regimen — to prevent TB and reduce death in

Pages